Validation & Proof Points

Clinical validation, institutional partnerships, and documented outcomes demonstrating Cliexa's market credibility.

Key Outcome Metrics

Visit Time Reduction

30%

Colorado Arthritis Center pilot

Annual Savings

$30.8K

Single specialty practice ROI

Revenue Growth

64%

YoY revenue growth 2023-2024

Platform Revenue

$2.9M

2024 annual revenue

Clinical Validation Partners

Clinical Validation

Mayo Clinic Platform

cliexaAI Opioid Use Disorder (OUD) risk prediction solution qualified on Mayo Clinic Platform (January 2026). XGBoost-based predictive algorithm combined with cliexa's rules engine identifies and stratifies patients at risk of OUD.

First company selected for Mayo Clinic Platform_Accelerate program

Strategic Partnership & Investment

American College of Cardiology

Co-developed cliexa-PULSE, a remote monitoring platform for cardiovascular care (atrial fibrillation, hypertension, heart failure). ACC Innovation Program participant since 2021. ACC is both a development partner and equity investor.

Channel to thousands of ACC member cardiology clinics

Clinical Pilot & Deployment

Colorado Arthritis Center

Piloted cliexa-RA on cliexaTrac for real-time tracking of patient symptoms and disease activity. Patients complete standardized assessments via app before visits, with auto-scored results in Greenway Health EMR.

30% reduction in patient visit time, $30.8K annual savings

Academic Research

University of Colorado College of Nursing

Collaborated to develop Info Viz for Health, a visual communication and education tool for HIV patients. Addressed low health literacy with intuitive care plan delivery via cliexa platform.

Improved CD4 counts and lower viral loads for tool users

Strategic Channel Partners

Government/Federal Channel

BDR Solutions

Strategic partnership to support federal health agencies. BDR works with U.S. Defense Health Agency (DHA), Veterans Affairs, and Military Health System. Recently awarded DHA's 'Digital Front Door' initiative.

Healthcare Advisory

Spring Parker

Alliance to jointly deliver performance improvement services. Spring Parker's consulting team identifies workflow and revenue challenges; Cliexa's technology is brought in as enabling solution.

International Expansion

Diginova Health

Partnership for Middle East market entry. Deploying cliexa's AI platform across hospitals in UAE to optimize operations, revenue cycle, and patient outcomes.

Clinical Validation

  • Clinical Rules Engine validated since 2016
  • Mayo Clinic Platform OUD solution qualification
  • NIH Small Business Grant recipient
  • Colorado Advanced Industries grant

Trusted Institutions

  • Columbia University Medical Center
  • Kartini Clinic (pediatric eating disorders)
  • Multiple specialty practices nationwide
  • Government health systems via BDR

Technical Credibility

  • Azure Marketplace listing (cliexaARCH)
  • Athenahealth Marketplace integration
  • FHIR/SMART on FHIR compliance
  • EMR-agnostic containerized architecture

Stakeholder Perspectives

"The cliexa platform represents a revolutionary approach to cardiovascular remote monitoring, enabling cardiologists to track symptoms, medications, and daily activity with seamless EMR integration."

American College of Cardiology Innovation Program

On cliexa-PULSE launch

"This collaboration addresses health literacy challenges among HIV-positive patients by conveying care plans in intuitive ways, resulting in improved clinical outcomes."

University of Colorado Nursing Research Team

On Info Viz for Health project

Market Validation

Total Addressable Market

$100B+

RCM ($65B) + CDSS ($1.2B) + RPM ($14B) combined U.S. market

Serviceable Market

Low $Bs

U.S. ambulatory care AI software for physician practices

Funding Raised

$6M

Including $2.74M in Feb 2025 from 18 investors